JASON ENSOR: Open Payments
NPI 1639854805 · NAPLES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$845 in 36 payments from 9 companies in 2025. Trend: 2023 $560 · 2024 $748 · 2025 $845
Food & beverage: $761Education: $84
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $291 |
| Madrigal Pharmaceuticals | 11 | $183 |
| PFIZER INC. | 8 | $124 |
| Janssen Biotech, Inc. | 1 | $84 |
| Phathom Pharmaceuticals, Inc. | 4 | $53 |
| Mauna Kea Technologies, Inc. | 1 | $49 |
| Braintree Laboratories, Inc. | 1 | $22 |
| Aimmune Therapeutics, Inc. | 1 | $21 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $19 |
Products named: RINVOQ, REZDIFFRA, VELSIPITY, TREMFYA, LINZESS, VOQUEZNA, SKYRIZI, SUTAB.
Industry payments across FL — which companies pay providers there.
